Brief: Brainstorm Cell Therapeutics Announces Pricing Of $7.5 Mln Registered Direct Offering
July 17 (Reuters) - Brainstorm Cell Therapeutics Inc
BCLI.O :
* BRAINSTORM CELL THERAPEUTICS ANNOUNCES PRICING OF $7.5
MILLION
REGISTERED DIRECT OFFERING
* EACH SHARE OF COMMON STOCK IS BEING OFFERED WITH A WARRANT
AT AN
OFFERING PRICE OF $1.85 PER SHARE
Source text for Eikon: ID:nPn1sSXwCa
Further company coverage: BCLI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brainstorm Cell Therapeutics
See all newsBrief: Brainstorm Appoints Former FDA Associate Commissioner Peter J. Pitts As Executive Chairman
Brief: Brainstorm Cell Therapeutics Announces First Quarter 2026 Financial Results And Provides Corporate Update
Brief: Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing At Premium To Market
Brief: Brainstorm Cell Therapeutics Announces Second Quarter Financial Results
Brainstorm Cell Therapeutics Inc expected to post a loss of 37 cents a share - Earnings Preview